By that imperfect logic, can we expect to see the shorters take their toll on the SP (share price) of FPH.AX? Like RMD, FPH is heavily invested in the OSA sleep mask business and it has similar growth % history and prospects. Considering that FPH currently has a much higher PE (49.8) than RMD (24.6) and with the pending impacts that GLP-1 drugs will have on all respiratory mask makers, FPH's SP should be about readly to crash, right?
RMD blue; FPH red
Ann: ResMed Announces Results for the Fourth Quarter of FY2023, page-225
-
- There are more pages in this discussion • 147 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$32.66 |
Change
0.140(0.43%) |
Mkt cap ! $20.99B | |||
| Open | High | Low | Value | Volume |
| $32.56 | $32.67 | $32.41 | $33.93M | 1.040M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3261 | $32.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $32.66 | 11222 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| RMD (ASX) Chart |